Subscribe to our Newsletters !!


    Preliminary examination recommends tuberculosis antibody might be restricting COVID-19 passings

    One of those emerging questions about this coronavirus that scientists have been attempting to understand is the reason developing countries are showing markedly lower rates of mortality in COVID-19 cases than anticipated. Research by assistant-professor Luis Escobar at this College of Natural Resources and Environment and 2 coworkers at the National Institutes of Health shows

    New T-cell-based immunization procedure gives more extensive insurance against occasional flu

    As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple

    Conceivable new anti-microbial created for drug-resistant pulmonary microorganism

    Scientists from Johns Hopkins University and Medicine have developed a potential new antibiotic for a pathogen that is notoriously resistant to drugs and often lethal for people with cystic fibrosis and other lung disorders. The pathogen, called Mycobacterium abscessus, is related to some better-known bacterium that causes tuberculosis and leprosy but has recently emerged as

    Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 – HaystackAnalytics Insights

    Mumbai, 23 March 2022: HaystackAnalytics, a Mumbai based health-tech startup, supported by the Department of Science & Technology, Govt of India, healthcare veterans like Dr Velumani, and private players such as GE Healthcare and Intel India Startup Program, reported an alarming 49% increase in the number of TB infections across the country, which largely remain

    Lancet Report on Tuberculosis in the time of COVID-19 (1) shows tuberculosis case detection was reduced by 25·1% in India from 2019

    Mumbai, March 25, 2022: The global tuberculosis burden remains substantial, with more than 10 million people newly ill per year. Dr Zarir F Udwadia, the consultant chest physician at P.D. Hinduja Hospital & MRC, who co-authored the Lancet report that aims to review the interactions between COVID-19 and tuberculosis, including the population-level impact of COVID-19 on tuberculosis